Laura Pentassuglia
-
- Chemotherapy-induced cardiotoxicity and mitigation 8
- Cardiomyopathy and Myosin Studies 1
- Oncology top 10%
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 6
- Biophysics top 10%
-
- Metabolism, Diabetes, and Cancer 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Cell Adhesion Molecules Research 3
-
- Neuroblastoma Research and Treatments 2
- Co-authors
- Douglas B. SawyerXuyang PengBilly ChenChee Chew LimFrancesco TimolatiChristian ZuppingerThomas SuterJean‐Claude Perriard
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Laura Pentassuglia
15 papers receiving 910 citations
Peers
Comparison fields: 5 of 87
- Cardiology and Cardiovascular Medicine 627
- Oncology 379
- Biophysics 38
- Pathology and Forensic Medicine 89
- Molecular Biology 328
Countries citing papers authored by Laura Pentassuglia
This map shows the geographic impact of Laura Pentassuglia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Pentassuglia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Pentassuglia more than expected).
Fields of papers citing papers by Laura Pentassuglia
This network shows the impact of papers produced by Laura Pentassuglia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Pentassuglia. The network helps show where Laura Pentassuglia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura Pentassuglia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 26 | |
| 2 | 2015 | 51 | |
| 3 | 2012 | 14 | |
| 4 | 2012 | 15 | |
| 5 | 2012 | 52 | |
| 6 | 2012 | 29 | |
| 7 | 2011 | 19 | |
| 8 | 2010 | 200 | |
| 9 | 2010 | 30 | |
| 10 | 2009 | 50 | |
| 11 | 2008 | 112 | |
| 12 | 2008 | 2 | |
| 13 | 2007 | 122 | |
| 14 | 2007 | 58 | |
| 15 | 2006 | 147 |
About Laura Pentassuglia
Laura Pentassuglia is a scholar working on Immunology and Allergy, Cardiology and Cardiovascular Medicine and Oncology, having authored 15 papers that have together received 927 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (8 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (6 papers), Cell Adhesion Molecules Research (3 papers), Neuroblastoma Research and Treatments (2 papers), Metabolism, Diabetes, and Cancer (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cardiomyopathy and Myosin Studies (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (627 citations), Oncology (379 citations) and Biophysics (38 citations). Laura Pentassuglia has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Douglas B. Sawyer, Xuyang Peng, Billy Chen, Chee Chew Lim, Francesco Timolati, Christian Zuppinger, Thomas Suter, Jean‐Claude Perriard, Marie‐Noëlle Giraud and Daniel Ott. Their work appears in journals such as PLoS ONE, Circulation Research and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.